Stocktoria
Maze Therapeutics, Inc. MAZE
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2025-01-31
Maze Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 809,214 | $24.2M |
| D. E. Shaw & Co., Inc. | 45,636 | $1.4M |
| MILLENNIUM MANAGEMENT LLC | 29,892 | $892,276 |
| AQR CAPITAL MANAGEMENT LLC | 27,945 | $834,158 |
| TWO SIGMA INVESTMENTS, LP | 15,845 | $472,973 |
| RENAISSANCE TECHNOLOGIES LLC | 15,800 | $471,630 |
Source: SEC EDGAR filings · CIK 0001842295 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.